Literature DB >> 17338474

Drug interaction between oral contraceptives and St. John's Wort: appropriateness of advice received from community pharmacists and health food store clerks.

Lord V Sarino1, Kristy H Dang, Nahal Dianat, Hera Djihanian, Neda Natanian, Karen Suchanek Hudmon, Peter J Ambrose.   

Abstract

OBJECTIVE: To estimate the extent to which community pharmacists and health food store clerks provide appropriate advice regarding a drug interaction between oral contraceptives and St. John's wort (SJW).
DESIGN: Cross-sectional study.
SETTING: Three community pharmacy chains and three health food store chains in four highly populated counties in California. PARTICIPANTS: Community pharmacists (n=99) and health food store clerks (n=84). INTERVENTION: Investigators, posing as consumers, telephoned pharmacists and health food store clerks and asked the following question: "Is there a problem with taking SJW with birth control pills?" MAIN OUTCOME MEASURES: Respondents were classified based on their ability to correctly identify the drug interaction (yes or no) and on the overall appropriateness (i.e., the absence of incorrect advice) of their advice. Comparisons were made between men and women respondents and between pharmacists and health food store clerks.
RESULTS: Community pharmacists were more likely than health food store clerks to correctly identify the drug interaction (50.5% versus 10.9%; Xchi(1 df) = 54.32, P < 0.001). Overall, 31.8% of respondents provided inappropriate advice that implied the absence of a drug interaction (26.3% of 99 pharmacists and 34.8% of 184 health food store clerks; Xchi(1 df) = 2.15, P = 0.14). Appropriateness of advice varied significantly among the three pharmacy chains (P < 0.001) and the three health food store chains (P < 0.05). Responses did not differ by gender of respondents (P = 0.18).
CONCLUSION: Lack of awareness of the potentially serious drug interaction between SJW and oral contraceptives by those who sell these products places the public at risk. Training and education, more comprehensive product labeling, and policies to refer consumers to drug information centers are needed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17338474     DOI: 10.1331/1544-3191.47.1.42.sarino

Source DB:  PubMed          Journal:  J Am Pharm Assoc (2003)        ISSN: 1086-5802


  6 in total

1.  Pharmacists' knowledge and interest in developing counseling skills relating to oral contraceptives.

Authors:  Mohamed E K Amin
Journal:  Int J Clin Pharm       Date:  2016-02-12

2.  Science-based pharmacy education.

Authors:  David W Newton
Journal:  Am J Pharm Educ       Date:  2007-04-15       Impact factor: 2.047

3.  Evaluation of a required senior research project in a doctor of pharmacy curriculum.

Authors:  Doris J Kao; Karen Suchanek Hudmon; Robin L Corelli
Journal:  Am J Pharm Educ       Date:  2011-02-10       Impact factor: 2.047

4.  Provider and patient expectations for dietary supplement discussions.

Authors:  Derjung M Tarn; Jennifer R Guzmán; Jeffrey S Good; Neil S Wenger; Ian D Coulter; Debora A Paterniti
Journal:  J Gen Intern Med       Date:  2014-05-30       Impact factor: 5.128

5.  Barriers, knowledge, and training related to pharmacists' counselling on dietary and herbal supplements: a systematic review of qualitative studies.

Authors:  Jeremy Y Ng; Umair Tahir; Simran Dhaliwal
Journal:  BMC Health Serv Res       Date:  2021-05-25       Impact factor: 2.655

6.  Clinically relevant safety issues associated with St. John's wort product labels.

Authors:  Kevin A Clauson; Marile L Santamarina; Jennifer C Rutledge
Journal:  BMC Complement Altern Med       Date:  2008-07-17       Impact factor: 3.659

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.